Dedicated to Pharmaceutical Innovation

Impax Laboratories is a technology-based specialty pharmaceutical company utilizing our core competency in drug delivery and formulation expertise. We have a balanced business model consisting of; a successful generic business targeting high-value solid oral and alternative dosage form Abbreviated New Drug Applications (ANDA), and a branded business currently focused on internally developing Central Nervous System (CNS) products where we can deliver meaningful patient benefits and develop strong intellectual property positions.

Corporate Headquarters

Mailing address:
30831 Huntwood Ave.
Hayward, CA 94544
(510) 240-6000

Visitors:
31047 Genstar Rd.
Hayward, CA 94544
(510) 240-6000


Research Areas

We have a dual strategic focus that stretches across our generic division, Global Pharmaceuticals, and our branded division, Impax Pharmaceuticals.

Our generic business strategy is focused on targeting high-value solid oral and alternative dosage form ANDAs that are difficult to develop and that bring sustainable profitability. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niches, including products with the potential for six months of exclusivity for being first-to-file or first-to-market.

Our brand business strategy is focused on CNS disorders. We are applying our formulation expertise and clinical development experience to develop differentiated, modified or controlled-release versions of currently marketed drug products.


Growth Strategy

We are focused on adding to the growth our own innovations will bring with acquisitions of external growth opportunities. Our business development activities are focusing on technologies in new dosage forms, or products or companies where our core competency in creative technologies and methods can result in synergies from further technical innovation. These could be in either generic or proprietary opportunities complementary to our own creative efforts.